AR003104A1 - Metodo para inhibir neumonia pneumocystis carinii, giardia lamblia y cryptosporidium y compuestos utiles para ello. - Google Patents
Metodo para inhibir neumonia pneumocystis carinii, giardia lamblia y cryptosporidium y compuestos utiles para ello.Info
- Publication number
- AR003104A1 AR003104A1 ARP950100169A AR10016995A AR003104A1 AR 003104 A1 AR003104 A1 AR 003104A1 AR P950100169 A ARP950100169 A AR P950100169A AR 10016995 A AR10016995 A AR 10016995A AR 003104 A1 AR003104 A1 AR 003104A1
- Authority
- AR
- Argentina
- Prior art keywords
- aminoalkyl
- alkylaryl
- aryl
- group
- pneumocystis carinii
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Abstract
La presente invención ofrece métodos para el tratamiento de la neumonía Pneumocystis carinii, Giardia Lamblia, Cryptosporidium parvum en un sujetonecesitado de dicho tratamiento. Los métodos comprenden administrar a un sujeto un compuesto de fórmula (I) en la cual, R1 y R2 se seleccionan cada unoindependientemente del grupo formado por H, alquilo, C1-6, arilo, alquilarilo, aminoalquilo,aminoarilo, halógeno, oxialquilo, oxiarilo o oxiarilalquilo; R1 yR4 se seleccionan cada uno independientemente del grupo formado por H, alquilo C1-4, oxialquilo, alquilarilo, arilo, oxiarilo, aminoalquilo, aminoarilo ohalógeno; y X e Y están en posición para o meta y se seleccionan del grupo formado por H, alquilo bajo, oxialquilo y fórmula (II), en la cual cada R6 seselecciona independientemente del grupo formado por H, alquilo bajo, alcoxialquilo, hidroxialquilo, aminoalquilo, alquilaminoalquilo, cicloalquilo,arilo o alquilarilo o dos grupos R6 juntos representan C9-C10-alquilo,hidroxialquilo o alquileno; y R6 es H, hidroxi, alquilo bajo, alcoxialquilo,hidroxialquilo, aminoalquilo, alquilamino, alquilaminoalquilo, cicloalquilo, hidroxicicloalquilo, alcoxicicloalquilo, arilo o alquilarilo o salesfarmacéuticamenteaptas de los mismos. Los compuestos se administran en una cantidad efectiva para tratar la afección. La presente invención incluyetambién nuevos compuestos útiles para el tratamiento de neumonia Pneumocystis carinii, Giardia lambia, Crystosporidium parvum.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33948794A | 1994-11-14 | 1994-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR003104A1 true AR003104A1 (es) | 1998-07-08 |
Family
ID=23329224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP950100169A AR003104A1 (es) | 1994-11-14 | 1995-11-14 | Metodo para inhibir neumonia pneumocystis carinii, giardia lamblia y cryptosporidium y compuestos utiles para ello. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0792271B1 (es) |
JP (1) | JP4023753B2 (es) |
AR (1) | AR003104A1 (es) |
AT (1) | ATE213737T1 (es) |
AU (1) | AU692024B2 (es) |
CA (1) | CA2204898A1 (es) |
DE (1) | DE69525644T2 (es) |
ES (1) | ES2173988T3 (es) |
IL (1) | IL115875A (es) |
WO (1) | WO1996015126A1 (es) |
ZA (1) | ZA959661B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723495A (en) * | 1995-11-16 | 1998-03-03 | The University Of North Carolina At Chapel Hill | Benzamidoxime prodrugs as antipneumocystic agents |
US6008247A (en) * | 1998-02-27 | 1999-12-28 | The University Of North Carolina At Chapel Hill | 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents |
ATE239003T1 (de) | 1998-08-20 | 2003-05-15 | Univ North Carolina | Dibenzothiophene derivate und ihre verwendung |
EP1013649A1 (en) * | 1998-12-22 | 2000-06-28 | Chisso Corporation | Liquid crystal compounds incorporating furan ring, liquid crystal composition and liquid crystal display device |
GB2351081A (en) * | 1999-06-18 | 2000-12-20 | Lilly Forschung Gmbh | Pharmaceutically active imidazoline compounds and analogues thereof |
US7163955B2 (en) | 2001-01-13 | 2007-01-16 | The University Of North Carolina At Chapel Hill | Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
US7256203B2 (en) * | 2002-11-27 | 2007-08-14 | The University Of North Carolina At Chapel Hill | Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
US7262223B2 (en) | 2004-01-23 | 2007-08-28 | Neurochem (International) Limited | Amidine derivatives for treating amyloidosis |
EP2034981A1 (en) * | 2006-03-27 | 2009-03-18 | The Government of the United States of America as Represented by The Department of Health and Human Services | Diamidine inhibitors of tdp1 |
-
1995
- 1995-11-05 IL IL11587595A patent/IL115875A/xx not_active IP Right Cessation
- 1995-11-13 JP JP51632796A patent/JP4023753B2/ja not_active Expired - Fee Related
- 1995-11-13 ES ES95941407T patent/ES2173988T3/es not_active Expired - Lifetime
- 1995-11-13 DE DE69525644T patent/DE69525644T2/de not_active Expired - Fee Related
- 1995-11-13 AU AU42838/96A patent/AU692024B2/en not_active Ceased
- 1995-11-13 CA CA002204898A patent/CA2204898A1/en not_active Abandoned
- 1995-11-13 AT AT95941407T patent/ATE213737T1/de not_active IP Right Cessation
- 1995-11-13 WO PCT/US1995/014893 patent/WO1996015126A1/en active IP Right Grant
- 1995-11-13 EP EP95941407A patent/EP0792271B1/en not_active Expired - Lifetime
- 1995-11-14 ZA ZA959661A patent/ZA959661B/xx unknown
- 1995-11-14 AR ARP950100169A patent/AR003104A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
DE69525644T2 (de) | 2002-10-17 |
CA2204898A1 (en) | 1996-05-23 |
EP0792271A1 (en) | 1997-09-03 |
JP4023753B2 (ja) | 2007-12-19 |
ATE213737T1 (de) | 2002-03-15 |
IL115875A (en) | 2000-12-06 |
JPH10508857A (ja) | 1998-09-02 |
DE69525644D1 (de) | 2002-04-04 |
MX9703611A (es) | 1998-07-31 |
ZA959661B (en) | 1996-05-29 |
EP0792271B1 (en) | 2002-02-27 |
ES2173988T3 (es) | 2002-11-01 |
AU4283896A (en) | 1996-06-06 |
WO1996015126A1 (en) | 1996-05-23 |
AU692024B2 (en) | 1998-05-28 |
IL115875A0 (en) | 1996-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2203274C2 (ru) | Спироциклические ингибиторы металлопротеаз | |
AR003104A1 (es) | Metodo para inhibir neumonia pneumocystis carinii, giardia lamblia y cryptosporidium y compuestos utiles para ello. | |
ES8603699A1 (es) | Metodo de obtener derivados de 1,4-dihidropiridinas | |
ATE117553T1 (de) | Substituierte dihydroisochinolinone und verwandte verbindungen als verstärker der letalen effekte von bestrahlung und bestimmten chemotherapeutika; ausgewählte verbindungen, analoga und verfahren. | |
EA200001146A1 (ru) | Производные изотиазола, применимые в качестве противораковых агентов | |
MXPA02002505A (es) | Nueva clase de agentes de citodiferenciacion e inhibidores de histona desacetilasa y metodos de utilizacion de los mismos. | |
ATE130514T1 (de) | Verwendung von stickstoff enthaltenden makrozyklen zur behandlung retroviraler infektionen. | |
DE69529670D1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
YU49101A (sh) | Karboksiaril supstituisani difenil karbamidi kao inhibitori raf kinaze | |
ATE106737T1 (de) | Pharmazeutische zusammensetzungen zur behandlung gastrointestinaler störungen. | |
LU88317I2 (fr) | Chlorhydrate d'esmolol (Brevibloc) | |
RU2002125495A (ru) | Гидроксифенил-пиперидин-4-илиден-метил-бензамидные производные для лечения боли | |
NO159091C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive xantinderivater. | |
DE3878313D1 (de) | Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. | |
RU97103983A (ru) | Лекарственные композиции и производные триазина | |
ES2096073T3 (es) | Derivado de benzamida. | |
DE68923151D1 (de) | Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen. | |
NO864443D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater. | |
NO811798L (no) | Nye substituerte 3-fenoksy-1-alkoksykarbonyl-alkylaminopropanoler-2 med beta-reseptorblokkerende egenskaper | |
ATE57927T1 (de) | Dithio-verbindungen, diese enthaltende pharmazeutische praeparate und deren verwendung. | |
WO1996015126B1 (en) | Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum | |
EP0309425A3 (en) | New heterocyclic derivatives | |
RU2001113272A (ru) | 3-тетрагидропиридин-4-илиндолы для лечения психотических нарушений | |
FI101849B1 (fi) | Antimikrobiset koostumukset ja niiden käyttö silmälääkkeiden säilömiseksi ja piilolinssien hoitamiseksi | |
ES543802A0 (es) | Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo n-carbamiloxi sustituido |